Calendar Iovance Biotherapeutics, Inc.

Equities

IOVA

US4622601007

Market Closed - Nasdaq 01:30:00 27/04/2024 am IST 5-day change 1st Jan Change
11.64 USD +0.87% Intraday chart for Iovance Biotherapeutics, Inc. +2.92% +43.17%

Chart calendar Iovance Biotherapeutics, Inc.

08b412003025a8a91f0c971b4f6dce.vRtNtc8TStwas4H1PUq_Mhi_391jTwC3mpOKIS2v3Hc.x0grjYdpJeRr1sCnDHj6Ak787-4hfS351sncaxudiEXxa3v7_VQyjmKKxA~1b87eb047d2ab07bae1a1089129a67c5

Upcoming events on Iovance Biotherapeutics, Inc.

07/05/2024 Q1 2024 Earnings Release (Projected)
01/06/2024 12:15 am American Society of Clinical Oncology Annual Meeting - Abstract 9505
01/06/2024 06:30 pm American Society of Clinical Oncology Annual Meeting - Abstract 2552
01/06/2024 11:00 pm American Society of Clinical Oncology Annual Meeting - Abstract 9594
01/08/2024 Q2 2024 Earnings Release (Projected)
06/11/2024 Q3 2024 Earnings Release (Projected)
26/02/2025 Q4 2024 Earnings Release (Projected)

Past events on Iovance Biotherapeutics, Inc.

26/03/2024 11:00 pm H.C. Wainwright Cell Therapy Virtual Conference
12/03/2024 08:15 pm Barclays Global Healthcare Conference
04/03/2024 09:40 pm TD Cowen Health Care Conference
29/02/2024 03:00 am Q4 2023 Earnings Call
29/02/2024 02:31 am Q4 2023 Earnings Release
17/02/2024 02:45 am AMTAGVI™ FDA Approval Call
08/11/2023 03:00 am Q3 2023 Earnings Call
08/11/2023 02:31 am Q3 2023 Earnings Release
04/11/2023 09:30 pm Society for Immunotherapy of Cancer Meeting - Long-term Efficacy and Safety of Lifileucel Tumor
04/11/2023 09:30 pm Society for Immunotherapy of Cancer Meeting - Study of Lifileucel Tumor Infiltrating Lymphocyte
03/11/2023 09:30 pm Society for Immunotherapy of Cancer Meeting
21/10/2023 06:45 pm European Society for Medical Oncology Congress
12/09/2023 08:45 am International Association for the Study of Lung Cancer World Conference - Adam J. Schoenfeld
11/09/2023 03:30 pm International Association for the Study of Lung Cancer World Conference - Dean Fennell
07/09/2023 10:15 pm Wells Fargo Healthcare Conference
09/08/2023 02:00 am Q2 2023 Earnings Call
09/08/2023 01:31 am Q2 2023 Earnings Release
27/06/2023 02:30 am Investor Meeting - Key Opinion Leaders
09/06/2023 08:30 pm Jefferies Global Healthcare Conference
06/06/2023 08:30 pm Annual General Meeting

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
1,19
2,12
-44.03%

161

EBITDA
Million USD
Released
Forecast
Spread
0,00
0,00
-
-261
-256
-1.87%
-340
-330
-2.8%
-390
-389
-0.09%
-449
-420
-6.87%

-302

EBIT
Million USD
Released
Forecast
Spread
-207
-196
-5.73%
-262
-260
-0.63%
-343
-331
-3.63%
-399
-395
-0.91%
-461
-451
-2.01%

-359

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-198
-187
-5.92%
-260
-257
-0.88%
-342
-330
-3.78%
-396
-394
-0.52%
-448
-440
-1.63%

-352

Net income
Million USD
Released
Forecast
Spread
-198
-187
-5.92%
-260
-257
-0.92%
-342
-330
-3.78%
-396
-394
-0.52%
-444
-439
-1.17%

-352

EPS
USD
Released
Forecast
Spread
-1,59
-1,50
-6.14%
-1,88
-1,85
-1.9%
-2,23
-2,15
-3.63%
-2,49
-2,49
-0.15%
-1,89
-1,88
-0.8%

-1,30

Announcement Date25/02/2025/02/2124/02/2228/02/2328/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,24
5,38
-95.57%
0,47
4,89
-90.4%
0,48
1,40
-65.55%

2,09


30,5


60,6


77,3


119

EBITDA
Million USD
Released
Forecast
Spread
-98,1
-88,2
-11.25%
-89,9
-100
10.26%
-97,5
-101
3.19%
-97,9
-106
7.78%
-104
-105
1.12%
-108
-110
1.56%
-107









-128


-129


-128


-132




EBIT
Million USD
Released
Forecast
Spread
-99,5
-87,4
-13.83%
-91,7
-100
8.67%
-99,7
-96,0
-3.87%
-100
-102
1.28%
-107
-103
-3.46%
-111
-111
0.11%
-110
-172
36.16%
-118
-109
-8.53%
-121
-112
-8.09%

-111


-97,7


-76,0


-67,0


-43,8

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-99,3
-86,8
-14.45%
-91,6
-100
8.5%
-99,3
-95,9
-3.55%
-99,6
-100
0.76%
-105
-103
-2.07%
-107
-131
17.98%
-107
-171
37.27%
-115
-107
-7.19%
-118
-111
-6.41%

-113


-98,2


-78,4


-73,1


-40,8

Net income
Million USD
Released
Forecast
Spread
-99,3
-86,8
-14.45%
-91,6
-100
8.5%
-99,3
-95,9
-3.55%
-99,6
-100
0.49%
-105
-103
-2.07%
-107
-131
17.98%
-107
-171
37.55%
-114
-107
-6.04%
-116
-111
-4.97%

-113


-98,2


-78,5


-73,1


-40,8

EPS
USD
Released
Forecast
Spread
-0,63
-0,56
-13.05%
-0,58
-0,64
9.38%
-0,63
-0,61
-4.05%
-0,63
-0,64
1.14%
-0,64
-0,64
-0.43%
-0,50
-0,75
33.42%
-0,47
-0,85
44.79%
-0,46
-0,45
-1.77%
-0,45
-0,44
-2.51%

-0,43


-0,36


-0,29


-0,27


-0,06

Announcement Date24/02/2205/05/2204/08/2203/11/2228/02/2309/05/2308/08/2307/11/2328/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. IOVA Stock
  4. Calendar Iovance Biotherapeutics, Inc.